Summary report of the First International Conference on inhibitors in haemophilia A

Sebastien Lacroix-Desmazes; David W Scott; Jenny Goudemand; Marijke Van Den Berg; Michael Makris; Alice S Van Velzen; Elena Santagostino; David Lillicrap; Frits R Rosendaal; Anneliese Hilger; Zuben E Sauna; Johannes Oldenburg; Lorenzo Mantovani; M Elisa Mancuso; Craig Kessler; Charles R M Hay; Paul Knoebl; Giovanni Di Minno; Keith Hoots; Amanda Bok; Mark Brooker; Erica Buoso; Pier Mannuccio Mannucci; Flora Peyvandi

doi:10.2450/2016.0252-16

Summary report of the First International Conference on inhibitors in haemophilia A

Blood Transfus. 2017 Oct;15(6):568-576. doi: 10.2450/2016.0252-16. Epub 2016 Nov 25.

Authors

Sebastien Lacroix-Desmazes¹, David W Scott², Jenny Goudemand³, Marijke Van Den Berg⁴, Michael Makris⁵, Alice S Van Velzen⁶, Elena Santagostino^{7

8

9}, David Lillicrap¹⁰, Frits R Rosendaal¹¹, Anneliese Hilger¹², Zuben E Sauna¹³, Johannes Oldenburg¹⁴, Lorenzo Mantovani¹⁴, M Elisa Mancuso^{7

8}, Craig Kessler¹⁵, Charles R M Hay¹⁶, Paul Knoebl¹⁷, Giovanni Di Minno¹⁸, Keith Hoots¹⁹, Amanda Bok²⁰, Mark Brooker²¹, Erica Buoso²², Pier Mannuccio Mannucci⁷, Flora Peyvandi^{7

8

9}

Affiliations

¹ National Institute of Health and Medical Research (Institut National de la Santé et de la Recherche Medicale - INSERM), Paris, France.
² Department of Medicine (MED), Uniformed Service University of Health Sciences, Bethesda, MD, United States of America.
³ University of Lille 2, Lille, France.
⁴ University Hospital of Utrecht, Utrecht, the Netherlands.
⁵ Sheffield Haemophilia and Thrombosis Centre, Sheffield, United Kingdom.
⁶ Emma Children's Hospital, Academic Medical Centre Amsterdam, Amsterdam, the Netherlands.
⁷ "Angelo Bianchi Bonomi" Haemophilia and Thrombosis Centre, Milan, Italy.
⁸ IRCCS Ca' Granda Ospedale Maggiore Policlinico Foundation, Milan, Italy.
⁹ University of Milan, Milan, Italy.
¹⁰ Department of Pathology and Molecular Medicine Richardson Laboratory, Queen's University Kingston, Kingston, ON, Canada.
¹¹ Leiden University Medical Centre, Leiden, the Netherlands.
¹² Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, Langen, Germany.
¹³ Office of Blood Research and Review Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD, United States of America.
¹⁴ University Clinic Bonn Institute of Experimental Haematology and Transfusion Medicine, Bonn, Germany.
¹⁵ Division of Coagulation in the Department of Laboratory MedicineTherapeutic and Cellular Apheresis Unit, Comprehensive Hemophilia and Thrombophilia Treatment Center, Georgetown University, Washington DC, United States of America.
¹⁶ Department of Haematology, Manchester Royal Infirmary, Manchester, United Kingdom.
¹⁷ Medical University of Vienna Department of Medicine 1, Division of Haematology and Haemostasis, Vienna, Austria.
¹⁸ Department of Clinical and Experimental Medicine, University of Naples Federico II, Naples, Italy.
¹⁹ Division of Blood Diseases and Resources, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United States of America.
²⁰ European Haemophilia Consortium (EHC), Brussels, Belgium.
²¹ World Federation of Hemophilia, Montreal, QC, Canada.
²² Department of Pharmacological Sciences, University of Pavia, Pavia, Italy.

No abstract available

Publication types

Congress

MeSH terms

Autoantibodies / immunology
Blood Coagulation Factor Inhibitors / immunology*
Factor VIII / immunology*
Factor VIII / therapeutic use*
Hemophilia A / immunology*
Hemophilia A / therapy*
Humans
Immune Tolerance
Immunotherapy / methods
Isoantibodies / immunology

Substances

Autoantibodies
Blood Coagulation Factor Inhibitors
Isoantibodies
Factor VIII